 |
|
|
|
|
|
|
|
 |
Results for 'Nanobiotechnology' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Nanobiotechnologies
applications, markets and companies
|
September 2008 |
£1435 |
50 % |
Nanoparticulate Drug Delivery Systems
|
April 2007 |
£115 |
35 % |
Nanotechnology and MEMS 2003
The Race to Commercialize the Ultra-Small
|
August 2003 |
£1005 |
29.4 % |
Biomarkers
|
January 2008 |
£2225 |
26 % |
Antiviral Therapeutics
Technologies, Markets and Companies
|
September 2008 |
£1880 |
23 % |
Cytogenetics
technologies,markets and companies
|
September 2008 |
£1340 |
16.8 % |
U.S. Next Generation Bio-Tools for Accelerating Bio-Pharmaceutical Drug Discovery R&D
Technologies, Opportunities and Market
|
March 2001 |
£1400 |
15.4 % |
Life Science Tools and Technologies for Bio-Pharma R&D
Instruments, Tech Platforms, Informatics and Market
|
March 2003 |
£1005 |
13.65 % |
Emerging Opportunities in Cancer Nanomedicine
|
August 2006 |
£995 |
12.6 % |
BioChips & BioMEMS (Bio Microelectromechanical Systems) World Markets, Applications & Opportunities
2006-2011 Analysis & Forecasts
|
May 2006 |
£1205 |
12.25 % |
Executive Summary of the BioChips & BioMEMS (Biomedical Microelectromechanical Systems) Markets
2006-2011 Analysis & Forecasts
|
May 2006 |
£735 |
12.25 % |
RNAi
Technologies, Markets and Companies
|
September 2008 |
£2010 |
10.85 % |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£535 |
10.15 % |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£535 |
10.15 % |
Asia Pacific Biotechnology Market
2007-2010
|
June 2007 |
£1075 |
10.15 % |
Drug Delivery in Cancer
Technologies, Markets and Companies
|
September 2008 |
£2010 |
9.8 % |
Personalized Medicine
scientific & commercial aspects
|
September 2008 |
£2680 |
7.7 % |
Molecular Diagnostics
Technologies, Markets and Companies
|
September 2008 |
£3020 |
7 % |
Animal Biotechnology
Technologies, Markets and Companies
|
September 2008 |
£900 |
6.65 % |
Cell Therapy
Technologies, Markets and Companies
|
September 2008 |
£3020 |
6.3 % |
Pain Therapeutics
Drugs, Markets and Companies
|
September 2008 |
£1075 |
4.9 % |
Proteomics
Technologies, Markets and Companies
|
September 2008 |
£2345 |
4.9 % |
|
|
|
|
